Lexaria enters definitive agreements for immediate warrant exercises
Lexaria Bioscience said it entered definitive agreements for the immediate exercise of certain outstanding warrants, targeting approximately $5.9 million in gross proceeds.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.